Your browser doesn't support javascript.
loading
Quality of life improvements by durable pulmonary vein isolation in patients with atrial fibrillation.
Inagaki, Dai; Fukamizu, Seiji; Tokioka, Sayuri; Kawamura, Iwanari; Kitamura, Takeshi; Hojo, Rintaro; Sakurada, Harumizu; Hiraoka, Masayasu.
Afiliación
  • Inagaki D; Department of Cardiology, Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan.
  • Fukamizu S; Department of Cardiology, Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan.
  • Tokioka S; Department of Cardiology, Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan.
  • Kawamura I; Department of Cardiology, Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan.
  • Kitamura T; Department of Cardiology, Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan.
  • Hojo R; Department of Cardiology, Tokyo Metropolitan Hiroo Hospital, Tokyo, Japan.
  • Sakurada H; Department of Cardiology, Tokyo Metropolitan Health and Medical Corporation, Ohkubo Hospital, Tokyo, Japan.
  • Hiraoka M; Department of Cardiovascular Disease, Tokyo Medical and Dental University, Tokyo, Japan.
J Cardiovasc Electrophysiol ; 31(8): 2013-2021, 2020 08.
Article en En | MEDLINE | ID: mdl-32468685
ABSTRACT

INTRODUCTION:

Successful pulmonary vein isolation (PVI) can improve the quality of life (QOL) of patients with atrial fibrillation (AF). However, the role of durable PVI for such QOL improvement is not known. The aim of this study was to clarify the effectiveness of durable PVI in improving the QOL of patients with AF. METHODS AND

RESULTS:

We assessed 119 patients who underwent PVI (age 66.4 ± 9.6 years, 104 paroxysmal AF). A scheduled electrophysiological study was performed 6 months after the first PVI session-regardless of recurrence of AF-to assess the durability of PVI and to identify and re-isolate reconnected pulmonary veins. QOL scores were evaluated by an AF-specific QOL questionnaire and checked at baseline, 6 months, and 1 year after the first session. In patients without AF recurrence (nonrecurrence group, n = 93), the scores at 6 months improved compared with those at baseline; conversely, the scores did not improve in patients with AF recurrence (n = 26). Nevertheless, the scores at 1 year improved compared with those at 6 months in both groups. Within the nonrecurrence group, the score difference between 6 months and baseline was higher in the durable PVI group (n = 58) than that in the nondurable PVI group (n = 35).

CONCLUSIONS:

The QOL of AF patients improved by the resumption of sinus rhythm following PVI. Patients with durable PVI had increased QOL scores compared with those with nondurable PVI. The durability of PVI may achieve further improvements in the QOL of patients with AF.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Venas Pulmonares / Fibrilación Atrial / Ablación por Catéter Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Humans Idioma: En Revista: J Cardiovasc Electrophysiol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / FISIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Venas Pulmonares / Fibrilación Atrial / Ablación por Catéter Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Aged / Humans Idioma: En Revista: J Cardiovasc Electrophysiol Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA / FISIOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Japón